3/19
08:00 am
vyne
VYNE Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Medium
Report
VYNE Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
3/8
02:11 pm
vyne
What Makes VYNE Therapeutics Inc. (VYNE) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes VYNE Therapeutics Inc. (VYNE) a New Buy Stock [Yahoo! Finance]
3/3
07:25 am
vyne
VYNE Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
VYNE Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
2/29
03:42 pm
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
2/29
08:14 am
vyne
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update [Yahoo! Finance]
2/29
08:00 am
vyne
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
Medium
Report
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
2/27
08:17 am
vyne
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium [Yahoo! Finance]
Low
Report
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium [Yahoo! Finance]
2/27
08:00 am
vyne
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
Low
Report
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
2/21
08:00 am
vyne
VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Low
Report
VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
2/2
06:08 am
vyne
Favourable Signals For VYNE Therapeutics: Numerous Insiders Acquired Stock [Yahoo! Finance]
Medium
Report
Favourable Signals For VYNE Therapeutics: Numerous Insiders Acquired Stock [Yahoo! Finance]
1/10
08:13 am
vyne
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo [Yahoo! Finance]
Medium
Report
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo [Yahoo! Finance]
1/10
08:00 am
vyne
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
Medium
Report
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
1/3
08:12 am
vyne
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors [Yahoo! Finance]
Low
Report
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors [Yahoo! Finance]
1/3
08:00 am
vyne
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors
Low
Report
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors